PARIS, France—Use of 4-Fr devices is feasible for the majority of endovascular interventions, achieving similar technical success and primary patency to that of 6-fr devices, even in calcified ...
MANSFIELD, Mass.-- (BUSINESS WIRE)-- Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback